Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period

Recruiting N/A Interventional Study
Substance Use Disorders Pregnancy Related Contraception
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Health Services Research
Participants needed
400 (estimated)
Sponsor
University of Pittsburgh · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a study to determine the effect of a novel patient-centered, reproductive planning decision support tool developed by the research team called MyPath on postpartum contraceptive decision-making among women with SUDs.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria Prenatal Cohort: * Be greater than or equal to 18 years of age. * Be pregnant with an EGA of 22 to 37 weeks at enrollment. * Plan to deliver at research site. * Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a subst…
Contacts

Elizabeth Krans, MD

(412) 641-3532

kransee@upmc.edu

CONTACT

Samantha Mayo, BA

(412) 641-2248

mayos@upmc.edu

CONTACT